Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Arcturus Therapeutics Holdings Inc. (ARCT)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arcturus Therapeutics Holdings Inc. since year 2005.
Table 2 shows the detailed insider transactions of Arcturus Therapeutics Holdings Inc. since 2005.
The reporting company's ticker symbol is ARCT. The reporting company's CIK number is 1768224.
The total value of stock buying since 2005 is $270,117.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-09-12||Kummerfeld Keith C (See Remarks)||Buy||500||10.69||5,346|
|2019-08-29||Payne Joseph E (President and CEO)||Buy||5,000||11.22||56,100|
|2019-08-23||Sassine Andy (Chief Financial Officer)||Buy||10,000||10.90||109,000|
|2019-08-20||Farrell Peter C (Director)||Buy||4,432||10.85||48,087|
|2019-08-19||Farrell Peter C (Director)||Buy||4,681||11.02||51,584|
Insider trading activities including stock purchases, stock sales, and option exercises of ARCT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arcturus Therapeutics Holdings Inc. (symbol ARCT, CIK number 1768224) see the Securities and Exchange Commission (SEC) website.